About
iHealthScreen Inc is a healthcare technology company based in New York, founded in 2015. The company specializes in AI-driven, telemedicine software designed for the early detection and automated screening of retinal and systemic diseases. Their flagship product, iPredict™, is a HIPAA-compliant, Class II medical device that analyzes retinal images to identify conditions such as age-related macular degeneration, diabetic retinopathy, glaucoma, stroke, and coronary heart disease. The core service of iHealthScreen is a low-cost platform that allows trained medical assistants to capture and upload retinal images, receiving automated diagnostic reports within minutes. This system supports early diagnosis and risk prediction, aiming to improve patient outcomes through preventative medicine. iHealthScreen collaborates with healthcare institutions, including Mount Sinai Hospital and the Bangladesh Diabetes Society, to screen large populations, particularly targeting diabetic and elderly individuals at risk for vision loss and cardiovascular issues. The company is led by Dr. Alauddin Bhuiyan, who brings significant expertise in ophthalmology to the team.
Technologies
Keywords
Company Information
-
Employees 30
-
Founded 2015
-
Total Funding $337668
Location
3500 N Dupont Hwy, Dover, Delaware, United States, 19901